National Cardiogenic Shock Initiative: 1 Year Later

Video Chapters:The Impact of The Cardiogenic Shock Initiative (NCSI):...

Considerations for Impella vs. ECMO

Dr. Michael Tong, Director of Heart Transplantation; Dr. Edward Soltesz, Surgical Director; and Dr. Shinya Unai, Cardiovascular...

Dr. Michael Amponsah Cardiogenic Shock Case with Impella CP

Dr. Michael Amponsah of Central New York Cardiology/Mohawk Valley Health System shares a case of Impella CP for a non-ischemic...

The Door-to-Unloading (DTU) STEMI Safety & Feasibility Trial

Navin Kapur, MD, executive director of the CardioVascular Center for Research and Innovation at Tufts Medical Center, discusses...

Best Practice Protocols for Cardiogenic Shock Showing Improved Outcomes Within the WellStar System

Dr. Salvatore Mannino, Director of the Short-Term Mechanical Circulatory Support Program at WellStar Health System joins Dr. Se...

Identification of Complications and Early Management

Dr. Adhir Shroff of the University of Illinois at Chicago recently presented at the SCAI Fellows 2017 conference during a works...

Heart Team Approach to Treating Cardiogenic Shock

Dr. Alexander Truesdell of INOVA Heart and Vascular Institute compares his experience in combat medicine and combat medical car...

How to Better Evaluate, Identify and Manage Shock Patients

Recently, Abiomed’s platform of Impella® heart pumps received FDA approval for the treatment of patients experiencing cardio...

The FDA’s Shock Indication for the Impella

The FDA recently granted Abiomed approval to expand Impella™ 2.5 PMA to treat patients suffering cardiogenic shock follo...